Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the randomized, double‐blind Combination of Avodart and Tamsulosin (CombAT) trial
Year: 2011
Type: article
Source: British Journal of Urology
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Keywords: benign prostatic hyperplasia, dutasteride, tamsulosin, combination therapy, acute urinary retention, clinical progression, lower urinary tract symptoms, baseline predictors, prostate volume, prostate-specific antigen, maximum urinary flow rate, health-related quality of life, 5-alpha reductase inhibitors, alpha-blockers, post hoc analysis, body mass index
Open Access status: closed
OpenAlex ID: W65134806
